Pernilla Abrahamsson
Geschäftsführer bei LIPUM AB
Profil
Pernilla Abrahamsson is the founder of MD Biomedical AB.
She is currently the Chief Operating Officer at Lipum AB.
Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Aktive Positionen von Pernilla Abrahamsson
| Unternehmen | Position | Beginn |
|---|---|---|
| LIPUM AB | Geschäftsführer | 01.01.2019 |
Ehemalige bekannte Positionen von Pernilla Abrahamsson
| Unternehmen | Position | Ende |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01.04.2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Gründer | - |
Ausbildung von Pernilla Abrahamsson
| Umea Universitet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SENZIME AB | Health Technology |
| LIPUM AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
